Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 76.00 | |
5 mg | In stock | $ 228.00 | |
10 mg | In stock | $ 369.00 | |
25 mg | In stock | $ 622.00 | |
50 mg | In stock | $ 885.00 | |
100 mg | In stock | $ 1,190.00 | |
500 mg | In stock | $ 2,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 198.00 |
Description | KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions. |
Molecular Weight | 283.28 |
Formula | C15H13N3O3 |
CAS No. | 906669-07-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (458.91 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KPLH1130 906669-07-6 Metabolism PI3K/Akt/mTOR signaling Dehydrogenase PDK KPLH 1130 Pyruvate dehydrogenase kinase PDH kinase KPLH-1130 inhibit Inhibitor PDHK inhibitor